Company / Gross Profit per Share
Organon & Co. Gross Profit per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$12.85
FY2025
5-year range
$12.85 / $15.30
FY2022-FY2025
Trend
-11.6%
vs FY2024
Sector context
#4 of 29
Health Care
What the data says
Organon & Co.'s gross profit per share of $12.85 is higher than 86% of companies in the Health Care sector (FY2025). Gross Profit per Share has declined for 3 consecutive years, from $15.30 in FY2022 to $12.85 in FY2025.
Based on SEC 10-K filings.
12.85 in FY2025 with a 3-year CAGR of -5.7%. Top quartile in the Health Care sector.
Declined from $14.73 to $12.85 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+58.5% above sector average
Key checks
Key Insights
- Organon & Co.'s gross profit per share has declined for 3 consecutive years.
- In FY2025, gross profit per share decreased 11.6% year-over-year.
- Ranks #4 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.85 | -11.6% |
| FY2024 | $14.53 | -1.4% |
| FY2023 | $14.73 | -3.7% |
| FY2022 | $15.30 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026